###begin article-title 0
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN)</italic>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
To investigate the genetic association between unrelated Korean keratoconus patients and interleukin 1 alpha (IL1A), interleukin 1 beta (IL1B), and IL1 receptor antagonist (IL1RN) gene polymorphisms.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 463 466 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
We investigated the association between IL1A (, , and ), IL1B (, , , and ), and IL1RN (, , , and , variable number tandem repeat [VNTR]) polymorphisms in 100 unrelated Korean keratoconus patients. One hundred control individuals without any corneal disease were selected from the general population. Polymerase chain reaction (PCR) - restriction fragment length polymorphism (RFLP) analysis and direct sequencing were used to screen for genetic variations in the IL1 gene cluster. Haplotypes for the IL1 gene cluster were constructed using Haploview version 4.0.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 182 189 <span type="species:ncbi:9606">patient</span>
###xml 460 468 <span type="species:ncbi:9606">patients</span>
###xml 706 714 <span type="species:ncbi:9606">patients</span>
We analyzed a total of 12 polymorphic sites in the IL1 gene cluster. Among them, the -511 () and -31 () positions in the promoter region of IL1B were significantly different between patient and control groups. The C allele of  (-511C>T, p=0.022, odds ratio of risk [OR]=1.46, 95% confidence intervals [CI] 0.94<2.27) and the T allele of  (-31T>C, p=0.025, OR=1.43, 95% CI 0.92<2.22) were associated with a significantly increased risk of keratoconus in Korean patients. Linkage of the two alleles, -31*C and -511*T, was associated with an increased risk for keratoconus with OR=2.38 (p=0.012, 95% CI=1.116-5.046). The *C/*A genotype of  in IL1A intron 6 was significantly different between the keratoconus patients and control subjects (p=0.034, OR=0.59, 95% CI 0.32<1.11). Other polymorphisms did not show an association with keratoconus risk.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
This is the first report of IL1 gene cluster mutation screening in Korean keratoconus patients. Significant differences in allelic frequency of IL1B between keratoconus patients and the control group suggest that IL1B polymorphisms may play a role in the susceptibility of unrelated Koreans to develop keratoconus.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 616 624 <span type="species:ncbi:9606">patients</span>
Keratoconus (OMIM ) is a bilateral, asymmetric, chronic, progressive ectasia of the cornea characterized by the steepening and distortion of the cornea, thinning of the apical cornea, and corneal scarring, which leads to progressive myopic and irregular astigmatism [1-3]. Histologically, the keratoconic cornea stroma may become less than one-quarter its normal thickness thereby leading to extensive distortion [4]. The pathophysiological processes underlying the keratoconic cornea have yet to be fully elucidated, although various studies have suggested that keratoconus is associated with eye rubbing in atopic patients [2,5], contact lens wearing [6], increased proteinase activity [4,7], decreased levels of proteinase inhibitors [8-10], increased oxidative damage [11], and keratocyte apoptosis [12,13].
###end p 11
###begin p 12
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
Keratocyte apoptosis has been reported in 60% of keratoconic corneas and is triggered by the epithelial release of interleukin 1 (IL1), which is activated by chronic mechanical injury to the corneal epithelium [12,14]. More specifically, IL1 has been implicated as a damage mediator, which is a modulator that regulates the apoptotic process [15,16], in these eye rubbers. In addition, stromal thinning in keratoconus is caused by the stimulation of keratocyte apoptosis induced by IL1. For these reasons, IL1 has been suggested as a candidate gene for keratoconus.
###end p 12
###begin p 13
###xml 286 290 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 292 296 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 302 307 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 323 325 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 326 328 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 335 338 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 462 464 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 744 746 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 747 749 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 750 752 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
IL1 is a pleiotropic cytokine. It is involved in the inflammatory response, cell growth, and tissue repair in the cortex. The IL1 superfamily consists of three members, IL1 alpha (IL1alpha), IL1 beta (IL1beta, predominant form) and IL1 receptor antagonist (IL1Ra), which are encoded by IL1A, IL1B, and IL1RN, respectively [17,18]. The IL1 superfamily genes are located in tandem in a cluster on chromosome 2q14. This gene cluster contains several polymorphisms [19]. Among them, some polymorphisms are located within the regulatory regions of the genes. Their localization in regulatory regions suggests that they may modulate IL1 protein production by directly affecting transcription, leading to their association with altered levels of IL1 [18,20-22].
###end p 13
###begin p 14
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
###xml 487 495 <span type="species:ncbi:9606">patients</span>
The goal of this study was to elucidate whether polymorphisms in IL1A, IL1B, and IL1RN are associated with keratoconus in Korean patients. We determined the genotype frequencies of 11 single nucleotide polymorphisms (SNPs), which were associated with altered levels of cytokines, and one variable number tandem repeat (VNTR) marker in the IL1 gene cluster in unrelated Korean keratoconus patients. Identification of genetic factors that determine susceptibility to keratoconus in Korean patients may allow us to gain insight into the pathogenesis of keratoconus.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 138 146 <span type="species:ncbi:9606">patients</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
This study included 100 unrelated keratoconus patients of Korean descent with age ranging from 18 to 33 years old. All of the keratoconus patients were identified from the Korea Eye Tissue and Gene Bank related to Blindness in the Department of Ophthalmology at the Catholic University of Korea (Seoul, Korea). Appropriate informed consent was obtained from each subject, and all studies were performed according to the tenets of the Declaration of Helsinki. The patients were diagnosed with keratoconus based on the following criteria: (1) symptoms of keratoconus including the Munson sign, protrusion, Vogt's striae, corneal thickness, scarring, the Fleischer ring, signs of photokeratoscopy, signs of videokeratography, and refractive errors and (2) medical histories including age, sex, contact lens use, eye rubbing behavior, systemic disease, atopy, and connective tissue disease [2,23]. One hundred age-matched control individuals with no history of keratoconus were also enrolled from the Korea Eye Tissue and Gene Bank related to Blindness.
###end p 16
###begin p 17
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
DNA was extracted from peripheral blood samples using the QIAamp DNA blood kit (QIAGEN, Valencia, CA). Polymerase chain reaction (PCR) reactions were performed with 25 ng of genomic DNA as a template in a mixture of PCR buffer, 2.5 mM MgCl2, 200 nM dNTPs, 0.4 pmol of each primer, and 0.75 units of h-Taq polymerase (Solgent, Daejeon, Korea; Table 1) [19,24,25].
###end p 17
###begin title 18
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B,</italic>
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
Polymorphic sites of IL1A, IL1B, and IL1RN.
###end title 18
###begin p 19
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
Assay methoda: Screening method for polymorphic site and lists of restriction enzyme; Agarose: Agarose gel electrophoresis; Genotypesb: It was indicated restricted sizes by RFLP analysis and amplified products for VNTR
###end p 19
###begin p 20
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Biallelic polymorphisms in the IL1 gene cluster were determined by PCR-restriction fragment length polymorphism (RFLP) analysis and direct sequencing (Table 1). The IL1RN VNTR polymorphism was evaluated by identifying the number of repeats in the (86)n sequence using agarose gel electrophoresis and direct sequencing [19,24,25].
###end p 20
###begin p 21
###xml 213 214 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 743 745 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 885 887 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
The Hardy-Weinberg equilibrium (HWE) was calculated using the  web version 4.0 program. To determine statistically significant differences in genotype and allele frequencies between the two groups, we used the chi2 test or Fisher's exact test for the 2x2 contingency table file. The descriptive statistics for observed differences in allele or genotype distribution with the corresponding p values were analyzed using the  web software in combination with StatXact-8 software (Cytel Inc., Cambridge, MA). The strength of the association was estimated by odds ratio of risk (OR) and 95% confidence intervals (CI). Haplotype frequencies and associations were calculated with  (version 4.0) that uses the expectation maximization (EM) algorithm [26]. Haplotype distributions were evaluated by the permutation test on the basis of 10,000 replications to obtain the empirical significance [26]. Values of p<0.05 were considered statistically significant.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 154 162 154 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 275 282 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 358 361 358 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
###xml 422 430 <span type="species:ncbi:9606">patients</span>
We analyzed 11 SNPs and one VNTR marker in the IL1 gene cluster: , , and  for IL1A; , , , and  for IL1B; and , , , , and the (86)n VNTR marker for IL1RN (Figure 1). The IL1A, IL1B, and IL1RN genotypic and allelic frequencies in keratoconus patients are listed in Table 2 and Table 3. The genotype distributions of the variants of the 12 polymorphisms in the IL1 gene cluster among the control subjects and the keratoconus patients were in Hardy-Weinberg equilibrium.
###end p 23
###begin p 24
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
IL1A, IL1B, and IL1RN, showing polymorphic nucleotide sequences. The map of the three genes, which are located on 2q14, is according to the UCSC  Mar 2006 Assembly. The direction of transcription is shown above each gene by a horizontal arrow. Exons are shown as rectangles. Vertical lines indicate polymorphic sites evaluated in this study.
###end p 24
###begin title 25
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of IL1A and IL1B in keratoconus patients.
###end title 25
###begin p 26
The asterisk indicates that OR=0.59 and 95% CI=0.32<1.11. The double asterisk indicates that OR=1.96 and 95% CI=0.96<3.96. The triple asterisk indicates that OR=1.92 and 95% CI=0.95<3.90. N.S., not significant.
###end p 26
###begin title 27
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of IL1RN in keratoconus patients.
###end title 27
###begin p 28
N.S., not significant.
###end p 28
###begin p 29
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 137 144 <span type="species:ncbi:9606">patient</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 596 604 <span type="species:ncbi:9606">patients</span>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
###xml 865 873 <span type="species:ncbi:9606">patients</span>
Of the four SNPs in IL1B, the  (-31T>C) and  (-511C>T) positions in the promoter region of IL1B were significantly different between the patient and control groups. For  (-511 T>C), the frequency of the *C/*C genotype was higher in the patients (34.8%) than in control subjects (21.4%; p=0.025, OR=1.96, 95% CI 0.96<3.96). The *C allele frequency at  was also higher in the patients (56.5%) than in the control subjects (47.1%; p=0.022, OR=1.46, 95% CI 0.94<2.27). The distribution of  (-31C>T) *T/*T, *T/*C, and *C/*C genotype frequencies were 34.4, 41.9, and 23.7, respectively, in keratoconus patients and 21.4, 50.0, and 28.6, respectively, in control subjects. The *T/*T genotype frequency had a higher risk of occurring in keratoconus patients than in control subjects (p=0.027, OR=1.92, 95% CI 0.95<3.90). The allele frequency of *T was 55.4% in keratoconus patients and 46.4% in control subjects (p=0.025, OR=1.43, 95% CI 0.92<2.22).
###end p 29
###begin p 30
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
Of the three SNPs in IL1A, the *C/*A genotype for  in intron 6 was significantly different between keratoconus patients and control subjects (p=0.034, OR=0.59, 95% CI 0.32<1.11), but the allele frequencies were not significantly different between the groups. Other SNPs and the VNTR showed no significant genotype or allele frequency differences between keratoconus patients and control subjects.
###end p 30
###begin p 31
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
In the haplotype analysis, we identified three haplotype block sets, --- for Block A, - for Block B, and -- for Block C (Figure 2). The T-C haplotype in Block B was more prevalent in keratoconus patients than in control subjects and was associated with a higher risk of developing keratoconus (p=0.034, OR=1.58, 95% CI 1.018<2.448). In contrast, the T-T haplotype in Block B was less frequent in the keratoconus group compared with the control group (p=0.009; Table 4).
###end p 31
###begin p 32
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Haplotype structure of select SNPs in IL1A, IL1B, and IL1RN. We estimated the pairwise linkage disequilibrium (LD) by calculating pairwise D' and r2 based on marker-marker D'>0.70 and r2>0.80. The images were generated with the  software pack.
###end p 32
###begin title 33
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Haplotype analysis of the interleukin 1 genes in keratoconus patients.
###end title 33
###begin p 34
The asterisk indicates that OR=1.58 and 95% CI=1.018<2.448, and the double asterisk indicates that OR=0.04 and 95% CI=0.003<0.667.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 1333 1334 1333 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 1335 1336 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1337 1338 1337 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 490 498 <span type="species:ncbi:9606">patients</span>
Keratoconus is an abnormality of the interactive epithelial-stromal system that causes a shift in the delicate balance between keratocyte proliferation and apoptosis [12]. Using the TUNEL assay, Kim et al. [12] confirmed the presence of keratocyte apoptosis in keratoconus corneas and the absence of keratocyte apoptosis in normal corneas. Keratocyte apoptosis may be triggered by increased basal IL1 release [12,14,27]. Previous studies indicated that corneal fibroblasts from keratoconus patients express about three times more IL1A mRNA than those from a normal cornea [15,28]. Zhou et al. [29] reported that the IL1 protein level was higher in the epithelium and endothelium of the keratoconus corneas than in normal corneas. In addition, IL1 upregulates keratocyte expression of collagenases, metalloproteinases, and other enzymes [30,31]. These enzymes have important roles in the remodeling of collagen during corneal wound healing. For example, persistent rubbing of the eye is likely to produce corneal epithelial trauma and increase the release of IL1 [15,16,32,33]. This would provide a unifying explanation for the association between keratoconus and factors associated with mechanical corneal epithelial cell injury such as poorly fitted rigid contact lenses, excessive eye rubbing, and allergic ocular surface disease [2,4,5,34]. Therefore, it has been suggested that interleukins are central modulators of the response to corneal injury.
###end p 36
###begin p 37
###xml 257 259 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 260 262 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 502 506 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 508 512 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 518 523 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 676 678 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 714 718 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 947 951 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 961 965 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 990 992 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 993 995 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 1027 1031 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1125 1127 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 1128 1130 1089 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 1164 1166 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1188 1190 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 1282 1284 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1285 1287 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 1334 1338 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1421 1423 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 1520 1522 1468 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 1579 1583 1527 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1857 1859 1802 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1948 1952 1893 1897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 1964 1967 1909 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1981 1983 1926 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 1984 1986 1929 1931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 531 536 <span type="species:ncbi:9606">human</span>
The IL1 superfamily includes three secreted glycoproteins, IL1alpha, IL1beta, and IL1Ra. Two of these, IL1alpha and IL1beta, are biologically active while the third member, IL1Ra, is a receptor antagonist that modulates the effects of IL1alpha and IL1beta [18,19]. IL1alpha and IL1beta proteins are synthesized by a variety of cell types including activated macrophages, stimulated B lymphocytes, fibroblasts, and endothelial cells. They are powerful mediators of inflammation and the immune response. IL1A, IL1B, and IL1RN map to human chromosome 2q14. Gene variations that alter gene function are more likely to influence phenotypic characteristics such as risk of disease [18]. An in vivo study showed that the IL1A-889 *T allele was associated with increased IL1alpha and IL1beta protein levels. Furthermore, ex vivo analysis of lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells indicated that production of IL1alpha from IL1A with the IL1A-889*T allele increased [35,36]. The two promoter variants of IL1B, -511C>T and -31T>C SNPs, have been repeatedly associated with multiple clinical conditions [37,38] such as cardiovascular disease [39] and gastric cancer [40] as well as with clinically observed differences in the levels of IL1beta protein in vivo [39,41]. The *T allele at -31 in the TATA box of the IL1B promoter region is suspected to enhance gene expression and induction of IL1beta [42]. The -31 *C allele was associated with increased IL1beta levels and decreased IL1alpha levels [43]. It has been reported that the T and C variants at the IL1B -31 position regulate gene expression and differential binding of proteins. A specific haplotype, which is composed of the T allele at -511 and the C allele at -31, was significantly associated with a twofold to threefold increase in LPS-induced IL1beta protein secretion [21]. There was also nearly a complete linkage disequilibrium between -511C>T and -31T>C in IL1B based on a cis interaction [40,42].
###end p 37
###begin p 38
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RA</italic>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ILRN</italic>
###xml 492 494 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 495 497 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 598 603 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1RN</italic>
###xml 670 672 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r45">45</xref>
###xml 713 716 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
Some studies have suggested that the allelic polymorphism located within intron 2 of IL1RN play a role in differential modulating IL1 activity. The IL1RA*2 is associated with increased IL1Ra protein production in vitro [44]. The *C allele of +8006 C/T in exon 2 of IL1RN is associated with the VNTR allele 2 and is associated with lower expression of IL1Ra [45,46]. The IL1B-511C, IL1B-31T, and ILRN+8006T haplotype (C-T-T), which has been associated with lower levels of IL1beta expression [21,38], was present in the extended protective haplotype. This extended protective haplotype contains the IL1RN+8006T allele, which is associated with elevated IL1Ra expression [45]. Therefore, these studies suggest that IL1 gene cluster polymorphisms may affect susceptibility to the development of specific diseases and that linkage disequilibrium of functional polymorphisms may indicate increased risk of developing these diseases.
###end p 38
###begin p 39
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 600 604 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1A</italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
###xml 569 577 <span type="species:ncbi:9606">patients</span>
###xml 688 696 <span type="species:ncbi:9606">patients</span>
In the present study, we have reported the results of a mutation screening of interleukin 1 genes in unrelated Korean patients with keratoconus. In the screen of four SNPs of IL1B, the genotypes of -511 *C/*C and -31 *T/*T of IL1B SNPs were associated with a 1.96 fold and 1.92 fold greater risk of developing keratoconus, respectively, (p=0.025 and p=0.027, respectively), showing a strong statistical association with keratoconus in unrelated patients. Two IL1B SNPs, -31C/T and -511T/C, have been implicated as potential risk factors for keratoconus among unrelated patients. Of the three SNPs in IL1A, the *C/*A genotype of  in intron 6 differed significantly between the keratoconus patients and control subjects (p=0.034, OR=0.59, 95% CI 0.32<1.11), but the allele frequencies were not significantly different between the groups.
###end p 39
###begin p 40
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 260 268 <span type="species:ncbi:9606">patients</span>
The T-C haplotype of IL1B -31 and -511 was more prevalent in keratoconus patients than in control subjects and carried a higher risk of keratoconus (p=0.034, OR=1.58, 95% CI 1.018<2.448). The T-T haplotype of IL1B -31 and -511 was less frequent in keratoconus patients than in the control individuals (p=0.009), which was associated with protection.
###end p 40
###begin p 41
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1</italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 466 470 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 679 683 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
###xml 699 707 <span type="species:ncbi:9606">patients</span>
Our study is the first to report on IL1 gene cluster polymorphisms in Korean keratoconus patients. We detected two disease-associated SNPs,  (-31T>C) and  (-511C>T), in IL1B and a disease- associated haplotype, the IL1B-31T/-511C haplotype, which is associated with regulation of IL1alpha and IL1beta production. It proves that IL1 may have important roles as central modulators of keratoconus development. In conclusion, the present study suggests that two SNPs in IL1B predict keratoconus predisposition in unrelated Korean patients, although further research is necessary to elucidate the relationship between the expression levels of IL1alpha, IL1beta, and IL1Ra and SNPs of IL1B in keratoconus patients.
###end p 41
###begin title 42
Acknowledgments
###end title 42
###begin p 43
The authors thank the Korea Eye Tissue and Gene Bank at the Catholic University of Korea and the staff of the Department of Ophthalmology at St. Mary's Hospital. The authors thank M. Hwang for useful discussion.
###end p 43
###begin title 44
References
###end title 44
###begin article-title 45
Keratoconus and related noninflammatory corneal thinning disorders.
###end article-title 45
###begin article-title 46
Keratoconus.
###end article-title 46
###begin article-title 47
Keratoconus.
###end article-title 47
###begin article-title 48
The cascade hypothesis of keratoconus.
###end article-title 48
###begin article-title 49
Atopy and keratoconus: a multivariate analysis.
###end article-title 49
###begin article-title 50
Development of keratoconus after contact lens wear.
###end article-title 50
###begin article-title 51
Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors.
###end article-title 51
###begin article-title 52
Alpha-1 proteinase inhibitor levels in keratoconus.
###end article-title 52
###begin article-title 53
###xml 22 27 <span type="species:ncbi:9606">human</span>
Characterization of a human corneal metalloproteinase inhibitor (TIMP-1).
###end article-title 53
###begin article-title 54
Expression of degradative enzymes and protease inhibitors in corneas with keratoconus.
###end article-title 54
###begin article-title 55
###xml 32 37 <span type="species:ncbi:9606">human</span>
Evidence of oxidative stress in human corneal diseases.
###end article-title 55
###begin article-title 56
Keratoocyte apoptosis associated with keratoconus.
###end article-title 56
###begin article-title 57
Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease.
###end article-title 57
###begin article-title 58
Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing.
###end article-title 58
###begin article-title 59
###xml 18 23 <span type="species:ncbi:9606">human</span>
Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus.
###end article-title 59
###begin article-title 60
Evidence of apoptotic cell death in keratoconus.
###end article-title 60
###begin article-title 61
###xml 46 51 <span type="species:ncbi:9606">human</span>
A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes.
###end article-title 61
###begin article-title 62
The interleukin 1 family.
###end article-title 62
###begin article-title 63
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci.
###end article-title 63
###begin article-title 64
In vitro production of IL-1beta, IL-1 alpha, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.
###end article-title 64
###begin article-title 65
Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein.
###end article-title 65
###begin article-title 66
The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals.
###end article-title 66
###begin article-title 67
CLEK Study Group. A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS).
###end article-title 67
###begin article-title 68
The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis.
###end article-title 68
###begin article-title 69
Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis.
###end article-title 69
###begin article-title 70
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 70
###begin article-title 71
Keratocyte apoptosis following corneal surgery.
###end article-title 71
###begin article-title 72
###xml 22 27 <span type="species:ncbi:9606">human</span>
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing.
###end article-title 72
###begin article-title 73
Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians.
###end article-title 73
###begin article-title 74
Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop.
###end article-title 74
###begin article-title 75
Regulation of paracrine cytokine balance controlling collagenase synthesis by corneal cells.
###end article-title 75
###begin article-title 76
Stromal-epithelial interactions in the cornea.
###end article-title 76
###begin article-title 77
The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells.
###end article-title 77
###begin article-title 78
###xml 80 85 <span type="species:ncbi:9606">human</span>
Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts.
###end article-title 78
###begin article-title 79
Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha.
###end article-title 79
###begin article-title 80
Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease.
###end article-title 80
###begin article-title 81
Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumonia infection.
###end article-title 81
###begin article-title 82
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases.
###end article-title 82
###begin article-title 83
IGIGI Investigators. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro.
###end article-title 83
###begin article-title 84
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer.
###end article-title 84
###begin article-title 85
A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals.
###end article-title 85
###begin article-title 86
###xml 39 44 <span type="species:ncbi:9606">human</span>
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.
###end article-title 86
###begin article-title 87
###xml 126 134 <span type="species:ncbi:9606">patients</span>
Polymorphisms in the interleukin-1 gene influence the stratum corneum interleukin-1 alpha concentration in uninvolved skin of patients with chronic irritant contact dermatitis.
###end article-title 87
###begin article-title 88
###xml 30 35 <span type="species:ncbi:9606">human</span>
Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.
###end article-title 88
###begin article-title 89
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians.
###end article-title 89
###begin article-title 90
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.
###end article-title 90

